AI assistant
Sending…
LABCORP HOLDINGS INC. — Director's Dealing 2021
May 10, 2021
30237_dirs_2021-05-10_720cd8d7-f8b3-45aa-8e80-07ad09125a2e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2021-05-06
Reporting Person: Kirchgraber Paul R (CEO, Covance Drug Development)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-05-06 | Common Stock | S | 2500 | $276.55 | Disposed | 7844 | Direct |
More from LABCORP HOLDINGS INC.
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 26
Regulatory Filings
2026
May 22
Interim / Quarterly Report
2026
May 4
Regulatory Filings
2026
Apr 30
Annual Report
2026
Apr 10
Proxy Solicitation & Information Statement
2026
Apr 10
Regulatory Filings
2026
Apr 9
Regulatory Filings
2026
Mar 31
Director's Dealing
2026
Mar 30